Bjog-An International Journal of Obstetrics and Gynaecology最新文献

筛选
英文 中文
Labour Dynamics After Induction in Nulliparous IVF/ICSI and Spontaneous Pregnancies: A Matched Cohort Study 无产IVF/ICSI和自然妊娠诱导后的产程动态:一项匹配队列研究。
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-07-06 DOI: 10.1111/1471-0528.70300
Anna Seidenari, Sara Doroldi, Maria Cecilia Rinaldi, Sofia Calisti, Chiara Sollevanti, Cristina Scollo, Giuseppe Scibilia, Danila Morano, Antonio Farina
{"title":"Labour Dynamics After Induction in Nulliparous IVF/ICSI and Spontaneous Pregnancies: A Matched Cohort Study","authors":"Anna Seidenari,&nbsp;Sara Doroldi,&nbsp;Maria Cecilia Rinaldi,&nbsp;Sofia Calisti,&nbsp;Chiara Sollevanti,&nbsp;Cristina Scollo,&nbsp;Giuseppe Scibilia,&nbsp;Danila Morano,&nbsp;Antonio Farina","doi":"10.1111/1471-0528.70300","DOIUrl":"10.1111/1471-0528.70300","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To compare labour dynamics between nulliparous women with IVF/ICSI and spontaneous conception, and to assess the effect of epidural analgesia on the timing and incidence of vaginal birth using time-to-event methods.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Matched retrospective cohort study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Tertiary referral centre, Bologna, Italy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>A total of 124 IVF/ICSI and 248 maternal age–matched spontaneous conceptions undergoing induction of labour at ≥ 37 weeks between January 2019 and December 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Time-to-vaginal-delivery patterns were evaluated using smoothed instantaneous hazard (SIH) functions. Caesarean delivery was treated as a competing event, and subhazard ratios (sHR) were estimated using Fine–Grey regression. Analyses were stratified by epidural analgesia and adjusted for cervical dilation at induction, body mass index at term, and induction-related variables.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Labour dynamics and cumulative incidence of vaginal delivery over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 372 inductions, spontaneous conceptions had higher vaginal delivery rates than IVF/ICSI pregnancies (85.1% vs. 72.6%, <i>p</i> = 0.005) and shorter active labour (167 vs. 272 min, <i>p</i> &lt; 0.001). SIH curves showed earlier and more sustained peaks with late-labour rebound in spontaneous conceptions, whereas IVF/ICSI pregnancies exhibited flatter, persistently lower hazards. IVF/ICSI conception was associated with a significantly lower cumulative incidence of vaginal birth (sHR 0.67, <i>p</i> &lt; 0.001). Epidural analgesia delayed the timing but did not reduce the overall likelihood of vaginal delivery in spontaneous conceptions, while no significant effect was observed in IVF/ICSI pregnancies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Labour dynamics differ by mode of conception. IVF/ICSI pregnancies show reduced labour progression and earlier transition to caesarean delivery.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2267-2274"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148393730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuity, Not Sector, Drives Maternity Outcomes 推动生育成果的是连续性,而不是部门
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2025-09-29 DOI: 10.1111/1471-0528.70029
Carolyn Hastie
{"title":"Continuity, Not Sector, Drives Maternity Outcomes","authors":"Carolyn Hastie","doi":"10.1111/1471-0528.70029","DOIUrl":"10.1111/1471-0528.70029","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Blood Transfusion for Postpartum Haemorrhage and the Risk of Premature Ovarian Failure: A Nationwide Population-Based Cohort Study 产后出血输血与卵巢早衰风险的关系:一项基于全国人群的队列研究
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-08-04 DOI: 10.1111/1471-0528.70308
Min-A Kim, Ju Hyeong Son, Hyun-Joo Seol, Min-Jeong Oh, Geum Joon Cho, Young-Han Kim
{"title":"Association Between Blood Transfusion for Postpartum Haemorrhage and the Risk of Premature Ovarian Failure: A Nationwide Population-Based Cohort Study","authors":"Min-A Kim,&nbsp;Ju Hyeong Son,&nbsp;Hyun-Joo Seol,&nbsp;Min-Jeong Oh,&nbsp;Geum Joon Cho,&nbsp;Young-Han Kim","doi":"10.1111/1471-0528.70308","DOIUrl":"10.1111/1471-0528.70308","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To investigate the association between postpartum haemorrhage (PPH) severity and the subsequent risk of premature ovarian failure (POF), with blood transfusion used as a marker of severe PPH:&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Nationwide population-based retrospective cohort study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Korean National Health Insurance Service (KNHIS) database.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Women who delivered in Korea between 2015 and 2016.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Women were followed from delivery until diagnosis of POF, attainment of 40 years of age, or 31 December 2021. PPH was identified using International Classification of Diseases, 10th Revision (ICD-10) codes. Red blood cell (RBC) transfusion during the delivery hospitalization was used as the primary indicator of PPH severity. POF was defined as ovarian failure before 40 years of age. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) with 95% confidence intervals (CIs).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Incident premature ovarian failure.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Among 745 125 women, 78 225 (10.5%) experienced PPH and 3552 (0.48%) developed POF during follow-up. When stratified by transfusion status, women with PPH requiring RBC transfusion had a markedly higher risk of POF (adjusted HR 2.058, 95% CI 1.668–2.539, &lt;i&gt;p&lt;/i&gt; &lt; 0.0001), whereas PPH without transfusion was associated with only a borderline association (adjusted HR 1.108, 95% CI 0.993–1.237, &lt;i&gt;p&lt;/i&gt; = 0.066). A significant dose–response relationship was observed between RBC transfusion volume and POF risk, with adjusted HRs increasing progressively from 1.749 (95% CI 1.314–2.329) for 1 unit to 2.507 (95% CI 1.792–3.507) for 2–3 units and 2.894 (95% CI 1.439–5.820) for ≥ 4 units (p &lt; 0.0001).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Severe PPH requiring blood transfusion is associated with a substantially increased risk of premature ovarian failure in this nationwide population-based cohort. These findings support the impor","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2285-2292"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70308","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148671138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal Oestrogen Therapy for Postmenopausal Women Undergoing Prolapse Surgery: A Multicentre Double-Blind Randomised Placebo-Controlled Clinical Trial 阴道雌激素治疗绝经后妇女脱垂手术:一项多中心双盲随机安慰剂对照临床试验。
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-08-28 DOI: 10.1111/1471-0528.70311
Eva V. Vodegel, Krista van Rest, Leonie Speksnijder, Astrid Vollebregt, Albert Adriaanse, Eveline J. Roos, Franca Gerards, Wilbert Spaans, Marko Sikkema, Joggem Veen, Flora Vernooij, Marinus van der Ploeg, Jan-Paul W. R. Roovers, the EVA Study Group
{"title":"Vaginal Oestrogen Therapy for Postmenopausal Women Undergoing Prolapse Surgery: A Multicentre Double-Blind Randomised Placebo-Controlled Clinical Trial","authors":"Eva V. Vodegel,&nbsp;Krista van Rest,&nbsp;Leonie Speksnijder,&nbsp;Astrid Vollebregt,&nbsp;Albert Adriaanse,&nbsp;Eveline J. Roos,&nbsp;Franca Gerards,&nbsp;Wilbert Spaans,&nbsp;Marko Sikkema,&nbsp;Joggem Veen,&nbsp;Flora Vernooij,&nbsp;Marinus van der Ploeg,&nbsp;Jan-Paul W. R. Roovers,&nbsp;the EVA Study Group","doi":"10.1111/1471-0528.70311","DOIUrl":"10.1111/1471-0528.70311","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine whether vaginal oestrogen therapy improves outcomes after prolapse surgery in postmenopausal women.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Double-blind, randomised, placebo-controlled trial with 12 month follow-up.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Multicentre, 22 hospitals in the Netherlands.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Postmenopausal women with POP-Q stage ≥ 2 scheduled for primary native-tissue prolapse repair.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Women were randomised (1:1) to vaginal oestriol cream (1 mg/g) or identical placebo, started 4–6 weeks preoperatively and continued to 12 months postoperatively (twice-weekly maintenance).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measure&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Subjective improvement in prolapse symptoms at 12 months postoperatively, defined as “much” or “very much” improved on the Patient Global Impression of Improvement (PGI-I) scale.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In total 293 women participated, 57 women dropped out. At 12 months, 92% of women in the oestrogen group versus 80% in the placebo group reported improvement on the PGI-I scale (&lt;i&gt;p&lt;/i&gt; = 0.02). Pelvic floor-related quality of life was better in the oestrogen group (median score PFDI-20: 17 vs. 25, &lt;i&gt;p&lt;/i&gt; = 0.03), and fewer women reported discomfort/pain (EQ-5D-5L: 61% vs. 77%, &lt;i&gt;p&lt;/i&gt; = 0.04). Anatomical outcomes, composite surgical success, sexual function and reintervention rates did not differ between groups. The cream was easy to use; 80% would use it for 1 year if it provided meaningful health benefits.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Perioperative vaginal oestrogen improved patient-reported outcomes and pelvic floor-related quality of life at 12 months, without affecting anatomical outcomes. These findings support discussing vaginal oestrogen as an adjunctive treatment option in shared decision-making with postmenopausal women undergoing primary prolapse surgery.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Trial Registration&lt;/h3&gt;\u0000 \u0000 ","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2219-2227"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70311","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148841846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient and Clinician Perspectives on Postpartum Thromboembolism Risk and Pharmacologic Thromboprophylaxis Use: A Qualitative Study 患者和临床医生对产后血栓栓塞风险和药物预防使用的看法:一项定性研究
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-08-20 DOI: 10.1111/1471-0528.70321
Ann M. Bruno, Naomi O. Riches, Erin Rothwell, Robert M. Silver, Torri D. Metz
{"title":"Patient and Clinician Perspectives on Postpartum Thromboembolism Risk and Pharmacologic Thromboprophylaxis Use: A Qualitative Study","authors":"Ann M. Bruno,&nbsp;Naomi O. Riches,&nbsp;Erin Rothwell,&nbsp;Robert M. Silver,&nbsp;Torri D. Metz","doi":"10.1111/1471-0528.70321","DOIUrl":"10.1111/1471-0528.70321","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Pregnancy-associated venous thromboembolism (VTE) risk is highest after delivery, and many hospitals recommend pharmacologic thromboprophylaxis during this period. There is a paucity of data on patient counselling received and clinician counselling provided on VTE risk and thromboprophylaxis. We aimed to determine information needs, perspectives and priorities regarding postpartum VTE risk communication and thromboprophylaxis education among people undergoing caesarean delivery and their obstetric clinicians.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Qualitative study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Single academic medical centre.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Postpartum individuals after caesarean delivery and obstetric clinicians.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Semi-structured interviews were completed virtually by trained personnel with individuals within 12 weeks postpartum and obstetric clinicians to explore: (1) patient information needs on VTE risk communication; (2) perspectives on pharmacologic thromboprophylaxis; and (3) outcome priorities for decision-making around VTE and future research. Transcribed interviews were imported into a qualitative analytics software program. A standardized inductive coding framework was used in duplicate to identify themes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Qualitative data.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Fifteen patients and 10 obstetric clinicians were interviewed. Patients were educated on the risk for VTE after caesarean delivery and rationale for thromboprophylaxis. Although patients reported discomfort (e.g., bruising, injection site pain) from prophylaxis administration, they reflected a willingness to use this therapy to reduce their risk of VTE and protect themselves. Patients identified some gaps in knowledge, opportunities for enhanced materials for education and willingness to participate in research. Clinicians endorsed providing counselling on VTE risk and thromboprophylaxis but identified barriers and recognized uncertainties on optimal management. Clinicians valued research that will improve evidence-based guidelines.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;While routine education on VTE risk and thromboprophylaxis i","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2304-2313"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148767527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes After Retropubic and Transobturator Sling Procedures: Reoperation for Recurrent Stress Urinary Incontinence 耻骨后和经通气吊带手术后的长期结果:复发性压力性尿失禁的再手术
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-07-02 DOI: 10.1111/1471-0528.70295
Ayssa Teles Abrao Trad, Sherif A. El Nashar, Brian J. Linder, Annetta M. Madsen, John A. Occhino, John B. Gebhart, Michaela E. McGree, Angela J. Fought, Emanuel C. Trabuco
{"title":"Long-Term Outcomes After Retropubic and Transobturator Sling Procedures: Reoperation for Recurrent Stress Urinary Incontinence","authors":"Ayssa Teles Abrao Trad,&nbsp;Sherif A. El Nashar,&nbsp;Brian J. Linder,&nbsp;Annetta M. Madsen,&nbsp;John A. Occhino,&nbsp;John B. Gebhart,&nbsp;Michaela E. McGree,&nbsp;Angela J. Fought,&nbsp;Emanuel C. Trabuco","doi":"10.1111/1471-0528.70295","DOIUrl":"10.1111/1471-0528.70295","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate long-term failure rates and complications after retropubic and transobturator midurethral sling procedures for primary stress urinary incontinence (SUI).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective cohort study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Academic medical centre.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>A previously described cohort of patients (<i>n</i> = 1881) who underwent midurethral sling procedures (2002–2012) and a covariate-matched cohort of patients with retropubic (<i>n</i> = 570) or transobturator (<i>n</i> = 317) slings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Health record review with follow-up extended by 9 years (through December 31, 2022).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Treatment failure (reoperation for recurrent SUI) and procedure-associated complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The duration of assessment was extended by 6.9 years for the retropubic group and by 6.4 years for the transobturator group. The median (IQR) follow-up was 11.1 (5.1–14.5) years (retropubic, 11.4 [5.9–14.6]; transobturator, 9.6 [2.6–13.7]). Higher risk of reoperation was observed with transobturator (8.8%) than retropubic (4.4%) slings (unadjusted hazard ratio [HR], 2.29 [95% CI, 1.49–3.54]; <i>p</i> &lt; 0.001; covariate-matched analysis HR, 1.91 [95% CI, 1.15–3.17]; <i>p</i> = 0.01). The increased risk of reoperation with a transobturator sling was higher when the procedure was combined with prolapse repair (unadjusted HR, 6.34 [95% CI, 3.09–13.02]; <i>p</i> &lt; 0.001; covariate-matched analysis HR, 3.96 [95% CI, 1.35–11.58]; <i>p</i> = 0.01). Higher rates of reoperation for urinary retention were observed for the retropubic group than for the transobturator group (covariate-matched analysis HR, 8.39 [95% CI, 1.11–63.22]; <i>p</i> = 0.04).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In this long-term follow-up study, midurethral slings had a low failure rate. Women with SUI undergoing transobturator sling placement plus prolapse repair had a greater risk of reoperation. However, women with retropubic slings had a greater risk of urinary retention requiring intervention.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2238-2244"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148372423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell-Free Fetal DNA Testing for Single Gene Conditions (Scientific Impact Paper No. 80) 单基因条件下无细胞胎儿DNA检测(科学影响论文第80号)。
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-10-11 DOI: 10.1111/1471-0528.70333
F. Mone, M. Holder-Espinasse, N. J. Chandler, M. D. Kilby, N. Vora, S. Allen, the Royal College of Obstetricians and Gynaecologists
{"title":"Cell-Free Fetal DNA Testing for Single Gene Conditions (Scientific Impact Paper No. 80)","authors":"F. Mone,&nbsp;M. Holder-Espinasse,&nbsp;N. J. Chandler,&nbsp;M. D. Kilby,&nbsp;N. Vora,&nbsp;S. Allen,&nbsp;the Royal College of Obstetricians and Gynaecologists","doi":"10.1111/1471-0528.70333","DOIUrl":"10.1111/1471-0528.70333","url":null,"abstract":"&lt;p&gt;The DNA code represents a genetic instruction as to how the human body develops and works. A ‘spelling mistake’ in the DNA code of the developing fetus can lead to a single gene condition. Examples of single-gene conditions include cystic fibrosis, sickle cell disease and Huntington's disease.&lt;/p&gt;&lt;p&gt;Single gene conditions collectively affect 1 in 100 births and can be inherited from one or both parents, or can occur without any family history, arising spontaneously out of a one-off change (pathogenic variant) in a known gene. Sometimes there can be specific anomalies seen on the ultrasound scan that suggest this. Autosomal dominant inheritance is where a parent has the spelling mistake in their DNA and there is then a 1 in 2 (50%) chance that the baby will inherit the condition. Alternatively, both parents may be carriers of the spelling mistake within their DNA code but do not themselves have the condition (autosomal recessive inheritance), in which case there is then a 1 in 4 (25%) chance of having a baby with that condition. There are also X-linked (sex-linked) conditions where usually only boys can inherit the condition, while girls can be carriers.&lt;/p&gt;&lt;p&gt;Traditionally, when embarking on a pregnancy where there is a risk of a baby being affected with a genetic condition, invasive testing using amniocentesis (via a needle through the mother's abdomen to take a sample of amniotic fluid from around the baby) or chorionic villus sampling (via a needle through the mother's abdomen to take a sample from the placenta) is offered to the parents to obtain a sample of DNA from the baby to test for the condition. However, these tests are invasive involving a needle going into the womb and can carry a small miscarriage risk of around 1 in 200.&lt;/p&gt;&lt;p&gt;It is now known that DNA from the placenta (which represents the DNA in the baby) circulates in the mother's blood from early pregnancy. This is known as cell-free fetal DNA (cffDNA) and so is a potential source of genetic material that can be used to test the baby for selected genetic conditions. Discovery of cffDNA in the mother's blood now allows for testing for genetic conditions as early as the 8th week of pregnancy, commonly referred to as non-invasive prenatal diagnosis (NIPD). Its use has evolved in clinical practice from 2011 when it was originally developed to screen for common chromosome differences such as Down, Edwards and Patau syndromes and for this purpose is referred to as non-invasive prenatal screening or testing (NIPS/T). While the acronym of ‘NIPD’ is similar to ‘NIPS/T’ it is important to be clear that these test for different things, can be a screening or a diagnostic test and use different technological approaches.&lt;/p&gt;&lt;p&gt;The mother's own cell-free DNA (cfDNA) will also be present in the sample and must be distinguished from that of her developing fetus. NIPD is currently available in the UK through the National Health Service (NHS) for some limited scenarios, for example, where pare","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"e187-e195"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70333","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149171282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertensive Disorders of Pregnancy and the Long-Term Risk of Maternal Retinal and Ophthalmic Disease: A Systematic Review and Meta-Analysis 妊娠期高血压疾病与母体视网膜和眼部疾病的长期风险:一项系统综述和荟萃分析
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-07-15 DOI: 10.1111/1471-0528.70307
Peter Barrett, Cian Carey, Sinéad O'Riordan, Angela Ding Wu, Emma Wallace, Matilda Biba, Karolina Kublickiene, Fergus McCarthy, Ali Khashan
{"title":"Hypertensive Disorders of Pregnancy and the Long-Term Risk of Maternal Retinal and Ophthalmic Disease: A Systematic Review and Meta-Analysis","authors":"Peter Barrett,&nbsp;Cian Carey,&nbsp;Sinéad O'Riordan,&nbsp;Angela Ding Wu,&nbsp;Emma Wallace,&nbsp;Matilda Biba,&nbsp;Karolina Kublickiene,&nbsp;Fergus McCarthy,&nbsp;Ali Khashan","doi":"10.1111/1471-0528.70307","DOIUrl":"10.1111/1471-0528.70307","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hypertensive disorders of pregnancy (HDP) are associated with increased long-term risk of maternal cardio-metabolic disease, but links with future retinal diseases remain unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The objective of this study is to synthesise the published literature on HDP and subsequent retinal and other ophthalmic disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Search Strategy</h3>\u0000 \u0000 <p>Databases including PubMed, Embase, Web of Science, and Cochrane Library were searched to March 2026 following a pre-registered PROSPERO protocol, CRD42024589508.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Selection Criteria</h3>\u0000 \u0000 <p>These included: a population of parous women, exposure to HDP at least once, at least one primary outcome (retinal disease) or secondary outcome (other ophthalmic disease). Women with pre-pregnancy retinal/ophthalmic diseases were excluded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Collection and Analysis</h3>\u0000 \u0000 <p>Two reviewers independently screened studies, extracted data, and assessed bias using an adapted Newcastle-Ottawa tool. Random-effects meta-analyses were performed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 5673 studies retrieved, 13 were eligible for inclusion (2 450 072 participants). HDP was associated with increased risk of diabetic retinopathy (aRR 3.54, 95% CI 2.19–5.74), particularly after preeclampsia (aRR 4.24, 95% CI 3.51–5.12). HDP-exposed women were also at higher risk of non-diabetic retinopathy (aRR 3.65, 95% CI 1.18–11.33), retinal detachment (aRR 1.54, 95% CI 1.28–1.86), and retinal vascular occlusion (aRR 2.09, 95% CI 1.55–2.81). HDP-exposed women may also be at risk of hypertensive retinopathy and central serous chorioretinopathy, but aRRs did not reach statistical significance. Across individual studies, HDP-exposed women were reported to be at increased risk of cataract extraction, non-infectious uveitis, and choroidal neovascular age-related macular degeneration.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Women who experience HDP may be at future risk of retinal and other ophthalmic diseases, particularly diabetic retinopathy. Further observational research is required to confirm these associations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2208-2218"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70307","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148451561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Effects of Pelvic Floor Muscle Training Combined With Electrical Stimulation Biofeedback Among Women With Symptomatic Pelvic Organ Prolapse: A Randomised Controlled Trial 盆底肌肉训练联合电刺激生物反馈对有症状的盆腔器官脱垂妇女的长期影响:一项随机对照试验
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-08-12 DOI: 10.1111/1471-0528.70313
Min Li, Yuhan Lyu, Pingping Li, Yaxin Liang, Tianzi Gai, Qiubo Lyu, Shuai Huang, Lin Liang, Yue Yu, Xinyue Zhang
{"title":"Long-Term Effects of Pelvic Floor Muscle Training Combined With Electrical Stimulation Biofeedback Among Women With Symptomatic Pelvic Organ Prolapse: A Randomised Controlled Trial","authors":"Min Li,&nbsp;Yuhan Lyu,&nbsp;Pingping Li,&nbsp;Yaxin Liang,&nbsp;Tianzi Gai,&nbsp;Qiubo Lyu,&nbsp;Shuai Huang,&nbsp;Lin Liang,&nbsp;Yue Yu,&nbsp;Xinyue Zhang","doi":"10.1111/1471-0528.70313","DOIUrl":"10.1111/1471-0528.70313","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine whether adding electrical stimulation (ES) biofeedback to supervised pelvic floor muscle training (PFMT) provides additional long-term benefit in prolapse anatomy among women with symptomatic pelvic organ prolapse (POP).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Randomised controlled trial.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A tertiary hospital in Beijing, China.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Primiparas (20–40 years) with symptomatic pelvic organ prolapse quantitation (POP-Q) stage II to III at 42–60 days postpartum following a full-term, vaginal singleton delivery.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We randomised 220 participants (1:1) to the intervention group (PFMT+ES+biofeedback) or control group (PFMT-only) for a 12-week intervention. The PFMT-only group received supervised PFMT (15 min/session, three times/week). The PFMT+ES+biofeedback group received two weekly sessions of ES (10 min) with biofeedback-mediated PFMT (15 min), and one session of supervised PFMT.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Primary outcome was POP-Q stage at 24 months. Secondary outcomes included Pelvic Floor Impact Questionnaire Short Form-7 (PFIQ-7) score, pelvic floor muscle (PFM) strength, PFM electromyography values, and economic analysis.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;At 24 months, the proportion of participants with improved POP-Q stage was not significantly different between PFMT+ES + biofeedback and PFMT-only groups. PFM strength demonstrated significant improvement in PFMT+ES + biofeedback group. No significant differences were observed in PFIQ-7 score or PFM electromyography values. Adding ES cost more, but had similar quality-adjusted life years. No adverse events were reported.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A single course of ES biofeedback plus supervised PFMT provides limited long-term benefit in postpartum prolapse.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Trial Registration&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Chinese Clinical Trial Regist","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2228-2237"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70313","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148709492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Falling Use of Preconception Folic Acid Supplements and Neural Tube Defect Prevention 孕前叶酸补充剂与神经管缺陷预防的使用下降。
IF 4.8 1区 医学
Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2026-11-18 Epub Date: 2026-08-09 DOI: 10.1111/1471-0528.70310
Danielle Schoenaker, Judith Stephenson, Anna L. David, Sanhita Chakrabarti, Keith M. Godfrey
{"title":"Falling Use of Preconception Folic Acid Supplements and Neural Tube Defect Prevention","authors":"Danielle Schoenaker,&nbsp;Judith Stephenson,&nbsp;Anna L. David,&nbsp;Sanhita Chakrabarti,&nbsp;Keith M. Godfrey","doi":"10.1111/1471-0528.70310","DOIUrl":"10.1111/1471-0528.70310","url":null,"abstract":"&lt;p&gt;Recent national data from England show a concerning and worsening fall in women's use of folic acid supplements before pregnancy [&lt;span&gt;1&lt;/span&gt;]. These findings are particularly important as fortification of non-wholemeal wheat flour will be mandatory in the UK from December 2026. Folic acid supplement use remains recommended for women planning pregnancy, reflecting the low amount of folic acid that will be added (0.25 mg per 100 g of flour) and concerns about the lack of fortification of non-wheat and imported flours that are part of staple foods among minority and culturally diverse communities. England's experience highlights a broader challenge facing countries introducing partial fortification programmes: how to maximise the benefits of fortification while optimising and maintaining adequate folic acid supplement intake before conception. In England, uptake of folic acid supplements before pregnancy was already low and fell from 26% in 2020/21 to below 20% in 2024/25 (Figure 1) [&lt;span&gt;1&lt;/span&gt;], with stark inequalities by ethnicity and socioeconomic deprivation [&lt;span&gt;2&lt;/span&gt;]. Given the serious public health implications for women, babies and families, this trend requires urgent attention.&lt;/p&gt;&lt;p&gt;Women are actively encouraged to take folic acid during pregnancy: the proportion starting supplements once pregnancy is confirmed has increased slightly from 65% to 69% [&lt;span&gt;1&lt;/span&gt;]. However, this is too late to prevent neural tube defects (NTDs) and related adverse outcomes, as neural tube closure is usually complete by the end of the fourth week of gestation—often before pregnancy is recognised. The World Health Organization recommends that women take 400 μg folic acid daily from the time they begin trying to conceive until 12 weeks of gestation, with a higher dose for some women at increased risk [&lt;span&gt;2&lt;/span&gt;]. Yet adequate folic acid intake remains challenging in many countries and could become an even greater public health challenge if fortification policies create the mistaken perception that supplements are no longer needed.&lt;/p&gt;&lt;p&gt;Countries have adopted substantially different approaches to folic acid fortification. Of 193 countries reviewed in 2023, 69 had mandatory fortification policies, 47 had voluntary fortification, while 77 had no fortification policy [&lt;span&gt;3&lt;/span&gt;]. Mandatory fortification programmes are established across most of North and South America, Australia, New Zealand and several African countries, and have been associated with substantial reductions in NTD prevalence. In contrast, many European countries, China and parts of Africa continue to rely on voluntary fortification or have no national policy [&lt;span&gt;3&lt;/span&gt;]. National surveillance data on folic acid supplement use and NTD prevalence are therefore critical [&lt;span&gt;4&lt;/span&gt;], in particular to monitor prevalence rates when introducing fortification programmes that add small amounts and that may not fully reach all population groups.&lt;/p&gt;&lt;p&gt;Preconception f","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"133 13","pages":"2205-2207"},"PeriodicalIF":4.8,"publicationDate":"2026-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.70310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148702778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书